Login to Your Account

Under pressure

DUBLIN – Allergan plc threatened to disrupt Takeda Pharmaceutical Co. Ltd.'s ongoing wooing of Shire plc by confirming Thursday in response to press speculation that it was "in the early stages of considering a possible offer for Shire." 

more »

Our Habitat for All Things Science
GWAS in Chinese population implicates immune system in Alzheimer's disease

A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.

The search continues for promising biomarkers and effective disease-modifying therapies for AD. The current drug development approaches mainly target the disease's hallmark pathology of amyloid-beta (Abeta) protein accumulation in the brain leading to Abeta plaque deposition.



Partners in Focus